Leo J. Ostruszka, Ph.D.

Affiliations: 
2001 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Pharmacology
Google:
"Leo Ostruszka"

Parents

Sign in to add mentor
Donna S. Shewach grad student 2001 University of Michigan
 (Studies directed toward the mechanism of radiosensitization by 2',2'-difluoro-2'-deoxycytidine (gemcitabine).)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jones T, Ostruszka LJ, Fouladdel S, et al. (2018) Abstract 638: Microbubble enrichment of CTCs Cancer Research. 78: 638-638
Ladd B, O'Konek JJ, Ostruszka LJ, et al. (2011) Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovir. Cancer Gene Therapy. 18: 751-9
Robinson BW, Ostruszka L, Im MM, et al. (2004) Promising combination therapies with gemcitabine. Seminars in Oncology. 31: 2-12
Leu KM, Ostruszka LJ, Shewach D, et al. (2004) Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1706-12
Ostruszka LJ, Shewach DS. (2003) The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidine. Cancer Chemotherapy and Pharmacology. 52: 325-32
Boucher PD, Ostruszka LJ, Murphy PJ, et al. (2002) Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy. Gene Therapy. 9: 1023-30
Ostruszka LJ, Shewach DS. (2000) The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine. Cancer Research. 60: 6080-8
Boucher PD, Ostruszka LJ, Shewach DS. (2000) Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea. Cancer Research. 60: 1631-6
See more...